IESC vs PAC

IESC exhibits a weak Piotroski F-Score of 3/9, signaling deteriorating fundamental health despite strong surface-level profitability. The stock is severely overvalued, trading at $644.08, which is nearly 5x its Graham Number ($135.06) and significantly above its growth-based intrinsic value ($495.89). This valuation gap is compounded by heavy insider selling totaling over $50M and a technical trend score of 10/100. While growth metrics are impressive, the current price appears to have priced in several years of perfection, leaving significant downside risk toward the analyst target of $458.00.

PAC presents a dichotomy between elite operational profitability and concerning top-line contraction. The deterministic baseline shows a stable Piotroski F-Score of 6/9, though the Graham Number ($7.19) is irrelevant due to an extreme Price-to-Book ratio (1250.27), indicating the company is valued on growth and cash flow rather than assets. While the intrinsic value of $336.6 suggests significant upside, the current bearish technical trend (0/100) and negative YoY revenue growth (-20.60%) offset the strong margins and analyst 'buy' recommendations.